Clinical Determinants for Successful Circulating Tumor DNA Analysis in Prostate Cancer

BACKGROUND: Plasma-based cell-free DNA is an attractive biospecimen for assessing somatic mutations due to minimally-invasive real-time sampling. However, next generation sequencing (NGS) of cell-free DNA (cfDNA) may not be appropriate for all patients with advanced prostate cancer (PC). METHODS: Bl...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Prostate
Asıl Yazarlar: Schweizer, Michael T., Gulati, Roman, Beightol, Mallory, Konnick, Eric Q., Cheng, Heather H., Klemfuss, Nola, Sarkar, Navonil De, Yu, Evan Y., Montgomery, R. Bruce, Nelson, Peter S., Pritchard, Colin C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6589085/
https://ncbi.nlm.nih.gov/pubmed/30865311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23778
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller